Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sabbagh

Showing results (191-200 of 330) with videos related to

Pageof 33
Sort By:
Brain Pathology (Zurich, Switzerland)|February 29, 2012
Biochemical increase in phosphorylated alpha-synuclein precedes histopathology of Lewy-type synucleinopathiesLih-Fen Lue, Douglas G Walker, Charles H Adler, et al.
Biochemistry Insights|September 12, 2014
Molecular Differences and Similarities Between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of AmyloidosisChera L Maarouf, Tyler A Kokjohn, Charisse M Whiteside, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 13, 2022
Primary prevention recommendations to reduce the risk of cognitive declineMarwan N Sabbagh, Adriana Perez, Thomas M Holland, et al.
Alzheimer Disease and Associated Disorders|December 14, 2004
Case series of clinically probable dementia with Lewy bodies in two Native AmericansMarwan N Sabbagh, Nina B Silverberg, Douglas Walker, et al.
Current Alzheimer Research|September 1, 2009
Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and ADM N Sabbagh, K Cooper, J DeLange, et al.
Clinical and Experimental Medical Sciences|October 18, 2014
Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized CohortMichael Malek-Ahmadi, Vickram Kahlon, Charles H Adler, et al.
Neurological Research|August 15, 2012
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjectsChera L Maarouf, Thomas G Beach, Charles H Adler, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 24, 1998
Correlation of nicotinic binding with neurochemical markers in Alzheimer's diseaseM N Sabbagh, R T Reid, J Corey-Bloom, et al.
Parkinsonism & Related Disorders|July 10, 2012
Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's diseaseAnne Damian, Charles H Adler, Joseph G Hentz, et al.
Current Alzheimer Research|June 25, 2005
Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate ADD Larry Sparks, Marwan N Sabbagh, Donald J Connor, et al.
Pageof 33

Showing results (191-200 of 330) with videos related to

Sort By:
Pageof 33
Brain Pathology (Zurich, Switzerland)|February 29, 2012
Biochemical increase in phosphorylated alpha-synuclein precedes histopathology of Lewy-type synucleinopathiesLih-Fen Lue, Douglas G Walker, Charles H Adler, et al.
Biochemistry Insights|September 12, 2014
Molecular Differences and Similarities Between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of AmyloidosisChera L Maarouf, Tyler A Kokjohn, Charisse M Whiteside, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 13, 2022
Primary prevention recommendations to reduce the risk of cognitive declineMarwan N Sabbagh, Adriana Perez, Thomas M Holland, et al.
Alzheimer Disease and Associated Disorders|December 14, 2004
Case series of clinically probable dementia with Lewy bodies in two Native AmericansMarwan N Sabbagh, Nina B Silverberg, Douglas Walker, et al.
Current Alzheimer Research|September 1, 2009
Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and ADM N Sabbagh, K Cooper, J DeLange, et al.
Clinical and Experimental Medical Sciences|October 18, 2014
Prevalence of Hippocampal Sclerosis in a Clinicopathologically Characterized CohortMichael Malek-Ahmadi, Vickram Kahlon, Charles H Adler, et al.
Neurological Research|August 15, 2012
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjectsChera L Maarouf, Thomas G Beach, Charles H Adler, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 24, 1998
Correlation of nicotinic binding with neurochemical markers in Alzheimer's diseaseM N Sabbagh, R T Reid, J Corey-Bloom, et al.
Parkinsonism & Related Disorders|July 10, 2012
Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's diseaseAnne Damian, Charles H Adler, Joseph G Hentz, et al.
Current Alzheimer Research|June 25, 2005
Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate ADD Larry Sparks, Marwan N Sabbagh, Donald J Connor, et al.
Pageof 33